APA (7th ed.) Citation

H, Z., S, Z., X, Y., C, Z., L, W., K, L., . . . S, N. (2022). Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data. Frontiers in immunology, 13, 990143. https://doi.org/10.3389/fimmu.2022.990143

Chicago Style (17th ed.) Citation

H, Zhao, et al. "Identifying Enhancer-driven Subtype-specific Prognostic Markers in Breast Cancer Based on Multi-omics Data." Frontiers in Immunology 13 (2022): 990143. https://doi.org/10.3389/fimmu.2022.990143.

MLA (9th ed.) Citation

H, Zhao, et al. "Identifying Enhancer-driven Subtype-specific Prognostic Markers in Breast Cancer Based on Multi-omics Data." Frontiers in Immunology, vol. 13, 2022, p. 990143, https://doi.org/10.3389/fimmu.2022.990143.